Cross, Samuel, Claxton, Karl orcid.org/0000-0003-2002-4694 and Hill, Andrew (2026) Health costs of the UK-US trade deal on pharmaceuticals. BMJ (Clinical research ed.). e340588. ISSN: 1756-1833
Abstract
Samuel Cross, Karl Claxton, and Andrew Hill argue that diversion of billions of NHS funding to pay more for new drugs under the UK-US trade deal will harm public health and result in thousands of excess deaths
Metadata
| Item Type: | Article |
|---|---|
| Authors/Creators: |
|
| Dates: |
|
| Institution: | The University of York |
| Academic Units: | The University of York > Faculty of Social Sciences (York) > Centre for Health Economics (York) The University of York > Faculty of Arts and Humanities (York) > Archaeology (York) |
| Date Deposited: | 05 Aug 2026 12:00 |
| Last Modified: | 05 Aug 2026 23:11 |
| Published Version: | https://doi.org/10.1136/bmj-2026-340588 |
| Status: | Published |
| Refereed: | Yes |
| Identification Number: | 10.1136/bmj-2026-340588 |
| Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:244223 |
Download
Filename: bmj-2026-340588.full.pdf
Description: Health costs of the UK-US trade deal on pharmaceuticals
Licence: CC-BY-NC 2.5

CORE (COnnecting REpositories)
CORE (COnnecting REpositories)